{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:13:31Z","timestamp":1772003611001,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T00:00:00Z","timestamp":1157932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00223-006-0108-1","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T15:24:12Z","timestamp":1158161052000},"page":"262-272","source":"Crossref","is-referenced-by-count":53,"title":["Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength"],"prefix":"10.1007","volume":"79","author":[{"given":"J.","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. R.","family":"Recker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Y.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,11]]},"reference":[{"key":"108_CR1","first-page":"690","volume":"14","author":"DW Dempster","year":"1993","unstructured":"Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R (1993) Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690\u2013709","journal-title":"Endocr Rev"},{"key":"108_CR2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1471-4892(02)00154-6","volume":"2","author":"J Fox","year":"2002","unstructured":"Fox J (2002) Developments in parathyroid hormone and related peptides as bone-formation agents. Curr Opin Pharmacol 2:338\u2013344","journal-title":"Curr Opin Pharmacol"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/endo-129-1-421","volume":"129","author":"L Mosekilde","year":"1991","unstructured":"Mosekilde L, S\u00f8gaard CH, Danielsen CC, T\u00f8rring O (1991) The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1\u201334) and hPTH-(1\u201384). Endocrinology 129:421\u2013428","journal-title":"Endocrinology"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jbmr.5650080910","volume":"8","author":"C Ejersted","year":"1993","unstructured":"Ejersted C, Andreassen TT, Oxlund H, J\u00f8rgensen PH, Bak B, H\u00e4ggblad J, T\u00f8rring O, Nilsson MHL (1993) Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097\u20131101","journal-title":"J Bone Miner Res"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/endo.132.4.8462456","volume":"132","author":"DB Kimmel","year":"1993","unstructured":"Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR (1993) The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Endocrinology 132:1577\u20131584","journal-title":"Endocrinology"},{"key":"108_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1359\/jbmr.2001.16.1.157","volume":"16","author":"DB Burr","year":"2001","unstructured":"Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM (2001) Intermittently administered human parathyroid hormone (1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16:157\u2013165","journal-title":"J Bone Miner Res"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"108_CR8","first-page":"S56","volume":"20","author":"SL Greenspan","year":"2005","unstructured":"Greenspan SL, Bone HG, Marriott TB, Zanchetta JR, Ettinger MP, Hanley DA, Drezner MK, Miller PD (2005) Preventing the first vertebral fracture in postmenopausal women with low bone mass using PTH(1-84): results from the TOP Study [abstract]. J Bone Miner Res 20(suppl 1):S56","journal-title":"J Bone Miner Res"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A","volume":"246","author":"RG Erben","year":"1996","unstructured":"Erben RG (1996) Trabecular and endocortical bone surfaces in the rat: modeling or remodeling. Anat Rec 246:39\u201346","journal-title":"Anat Rec"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/B978-012098652-1\/50197-9","volume-title":"Principles of Bone Biology","author":"DB Kimmel","year":"2002","unstructured":"Kimmel DB (2002) Animal models in osteoporosis research. In: Bilezekian JP, Raisz LG, Rodan GA (eds) Principles of Bone Biology, 2nd ed. Academic Press, San Diego, pp 1635\u20131655","edition":"2"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S8756-3282(99)00212-4","volume":"25","author":"JS Thomsen","year":"1999","unstructured":"Thomsen JS, Mosekilde Li, Gasser JA (1999) Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats. Bone 25:561\u2013569","journal-title":"Bone"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(00)00448-8","volume":"28","author":"M Kneissel","year":"2001","unstructured":"Kneissel M, Boyde A, Gasser JA (2001) Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-84). Bone 28:237\u2013250","journal-title":"Bone"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.302.1.304","volume":"302","author":"M Sato","year":"2002","unstructured":"Sato M, Ma YL, Hock JM, Westmore MS, Vahle J, Villanueva A, Turner CH (2002) Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment. J Pharmacol Exp Ther 302:304\u2013313","journal-title":"J Pharmacol Exp Ther"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1073\/pnas.68.1.63","volume":"68","author":"JT Potts Jr","year":"1971","unstructured":"Potts JT Jr, Tregear GW, Keutmann HT, Niall HD, Sauer R, Deftos LJ, Dawson BF, Hogan ML, Aurbach GD (1971) Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci USA 68:63\u201367","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF03549782","volume":"53","author":"H Oxlund","year":"1993","unstructured":"Oxlund H, Ejersted C, Andreassen TT, T\u00f8rring O, Nilsson MHL (1993) Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation from both the periosteum and endosteum. Calcif Tissue Int 53:394\u2013399","journal-title":"Calcif Tissue Int"},{"key":"108_CR16","unstructured":"FDA (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis, http:\/\/www.fda.gov\/cder\/guidance\/osteo.pdf"},{"key":"108_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","volume":"14","author":"CH Turner","year":"1993","unstructured":"Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595\u2013608","journal-title":"Bone"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/endo-16-5-547","volume":"16","author":"H Selye","year":"1932","unstructured":"Selye H (1932) On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 16:547\u2013558","journal-title":"Endocrinology"},{"key":"108_CR20","first-page":"469","volume":"21","author":"J Reeve","year":"1976","unstructured":"Reeve J, Tregear JW, Parsons JA (1976) Preliminary trial of low doses of parathyroid hormone 1-34 peptide in treatment of osteoporosis. Clin Endocrinol 21:469\u2013477","journal-title":"Clin Endocrinol"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/endo-110-2-506","volume":"110","author":"CS Tam","year":"1982","unstructured":"Tam CS, Heersche JN, Murray TM, Parsons JA (1982) Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110:506\u2013512","journal-title":"Endocrinology"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/endo-125-4-2022","volume":"125","author":"JM Hock","year":"1989","unstructured":"Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ (1989) Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH(1-34) on bone in rats. Endocrinology 125:2022\u20132027","journal-title":"Endocrinology"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1210\/endo.134.5.8156913","volume":"134","author":"L Mosekilde","year":"1994","unstructured":"Mosekilde L, Danielsen CC, Gasser J (1994) The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats. Endocrinology 134:2126\u20132134","journal-title":"Endocrinology"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1359\/jbmr.2000.15.8.1517","volume":"15","author":"AF Stewart","year":"2000","unstructured":"Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM (2000) Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. J Bone Miner Res 15:1517\u20131525","journal-title":"J Bone Miner Res"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02678147","volume":"68","author":"P Morley","year":"2001","unstructured":"Morley P, Whitfield JF, Willick GE, Ross V, MacLean S, Barbier JR, Isaacs RJ, Andreassen TT (2001) The effect of monocyclic and bicyclic analogs of human parathyroid hormone (hPTH)-(1-31)NH2 on bone formation and mechanical strength in ovariectomized rats. Calcif Tissue Int 68:95\u2013101","journal-title":"Calcif Tissue Int"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/endo.132.2.8425497","volume":"132","author":"TJ Wronski","year":"1993","unstructured":"Wronski TJ, Yen CF, Qi H, Dann LM (1993) Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823\u2013831","journal-title":"Endocrinology"},{"key":"108_CR27","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.5650100616","volume":"10","author":"H Qi","year":"1995","unstructured":"Qi H, Li M, Wronski TJ (1995) A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Miner Res 10:948\u2013955","journal-title":"J Bone Miner Res"},{"issue":"suppl 1","key":"108_CR28","first-page":"S98","volume":"19","author":"CE Wilker","year":"2004","unstructured":"Wilker CE, Jolette J, Smith SY, Doyle N, Hardisty JF, Metcalfe AJ, Marriott TB, Fox J, Wells DS (2004) An observable carcinogenic effect dose level identified in Fischer 344 rats following daily treatment with PTH(1-84) for 2 years: role of the C-terminal PTH receptor [abstract]. J Bone Miner Res 19(suppl 1):S98","journal-title":"J Bone Miner Res"},{"key":"108_CR29","unstructured":"Physicians Desk Reference, 59th ed. (2005) Thomson Healthcare, Montvale, NJ, p 1842"},{"key":"108_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/JCD:4:1:13","volume":"4","author":"MP Akhter","year":"2001","unstructured":"Akhter MP, Kimmel DB, Recker RR (2001) Effect of parathyroid hormone (hPTH[1-84]) treatment on bone mass and strength in ovariectomized rats. J Clin Densitom 4:13\u201323","journal-title":"J Clin Densitom"},{"key":"108_CR31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S8756-3282(01)00582-8","volume":"29","author":"UT Iwaniec","year":"2001","unstructured":"Iwaniec UT, Samneg\u00e5rd E, Cullen DM, Kimmel DB (2001) Maintenance of cancellous bone in ovariectomized, human parathyroid hormone (hPTH[1-84])-treated rats by estrogen, risedronate, or reduced PTH. Bone 29:352\u2013360","journal-title":"Bone"},{"issue":"suppl 1","key":"108_CR32","first-page":"S98","volume":"20","author":"DW Dempster","year":"2005","unstructured":"Dempster DW, Moreau IA, Varela A, Smith SY, Ste-Marie L-G, Fox J, Newman MK, Recker RR (2005) Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months improves trabecular bone architecture: a study of iliac crest biopsies using micro-computed tomography [abstract]. J Bone Miner Res 20(suppl 1):S98","journal-title":"J Bone Miner Res"},{"key":"108_CR33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S8756-3282(01)00408-2","volume":"28","author":"E Samneg\u00e5rd","year":"2001","unstructured":"Samneg\u00e5rd E, Akhter MP, Recker RR (2001) Maintenance of vertebral body bone mass and strength by human parathyroid hormone treatment in ovariectomized rats. Bone 28:414\u2013422","journal-title":"Bone"},{"key":"108_CR34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(00)00446-4","volume":"28","author":"E Samneg\u00e5rd","year":"2001","unstructured":"Samneg\u00e5rd E, Iwaniec UT, Cullen DM, Kimmel DB, Recker RR (2001) Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats. Bone 28:251\u2013260","journal-title":"Bone"},{"key":"108_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s001980200000","volume":"13","author":"CH Turner","year":"2002","unstructured":"Turner CH (2002) Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 13:97\u2013104","journal-title":"Osteoporos Int"},{"key":"108_CR36","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2003-030768","volume":"88","author":"AB Hodsman","year":"2003","unstructured":"Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, Metcalfe AJ, Lindsay R (2003) Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88:5212\u20135120","journal-title":"J Clin Endocrinol Metab"},{"key":"108_CR37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207\u20131215","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"108_CR38","first-page":"S22","volume":"20","author":"CE Bogado","year":"2005","unstructured":"Bogado CE, Zanchetta JR, Mango A, Mathisen AL, Fox J, Newman MK (2005) Effects of parathyroid hormone 1-84 on cortical and trabecular bone at the hip as assessed by QCT: results at 18 months from the TOP study [abstract]. J Bone Miner Res 20(suppl 1):S22","journal-title":"J Bone Miner Res"},{"key":"108_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-002-1312-0","volume":"14","author":"Q Rehman","year":"2003","unstructured":"Rehman Q, Lang TF, Arnaud CD, Modin GW, Lane NE (2003) Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with osteoporosis. Osteoporos Int 14:77\u201381","journal-title":"Osteoporos Int"},{"key":"108_CR40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","volume":"18","author":"JR Zanchetta","year":"2003","unstructured":"Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539\u2013543","journal-title":"J Bone Miner Res"},{"key":"108_CR41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Ma YL, Nold JB (2002) Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol 30:312\u2013321","journal-title":"Toxicol Pathol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-006-0108-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0108-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T07:34:34Z","timestamp":1627803274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-006-0108-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s00223-006-0108-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,11]]}}}